Kelliann C. Fee-Schroeder

Concerns Across the Survivorship Trajectory: Results From a Survey of Cancer Survivors

Sheryl M. Ness, Janine Kokal, Kelliann C. Fee-Schroeder et al. · Oncology nursing forum · 2012 · 131 citations

Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy

Deirdre R. Pachman, Breanna L. Weisbrod, Drew K. Seisler et al. · Supportive Care in Cancer · 2014 · 95 citations · Full text

Peripheral Nerve Injury, Pilot Evaluation, Medicine +8

Implementation of preemptive DNA sequence–based pharmacogenomics testing across a large academic medical center: The Mayo-Baylor RIGHT 10K Study

Liewei Wang, Steven E. Scherer, Suzette J. Bielinski et al. · Genetics in Medicine · 2022 · 65 citations · Full text

Dna Sequencing, Sequencing, Mayo-baylor Right 10K +9

Nine-gene pharmacogenomics profile service: The Mayo Clinic experience

Eric T. Matey, Ashley Kate Ragan, Lance J. Oyen et al. · The Pharmacogenomics Journal · 2021 · 26 citations

Functional Genomics, Mayo Clinic Experience, Genetics +6

Empowering Individuals to Self-Manage Chemotherapy Side Effects

Kelliann C. Fee-Schroeder, Lisa Howell, Janine Kokal et al. · Clinical journal of oncology nursing · 2013 · 18 citations

Nursing, Family Medicine, Expert Knowledge +13